C.M. Fleming, H.T. Davis, R. Ratner, C.D. Brown, M.N. Ediger, E.L. Hull, R. Udell, and J.D. Maynard, �??Use of Near-Infrared Spectroscopy to Detect Diabetes Based on Noninvasive Skin Measurements,�?? poster presentation at the 3rd Annual Meeting of the Diabetes Technology Society, San Francisco, CA, November 6-8, 2003.
D.M. Haaland and E.V. Thomas, �??Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information,�?? Anal. Chem. 60, 1193-1202 (1988).
H.M. Heise, S. Haiber, D. Ihrig, M. Licht, M. Stücker and C. Moll, �??Non-Invasive Diabetes Screening By Near Infrared Spectroscopy,�?? poster presentation at the 3rd Annual Meeting of the Diabetes Technology Society, San Francisco, CA, November 6-8, 2003.
M.G. Muller, I. Georgakoudi, Q. Zhang, and M.S. Feld, �??Intrinsic fluorescence spectroscopy in turbid media: disentagling the effects of scattering and absorption,�?? Appl. Opt. 25, 4633-4646 (2001).
J. Wu, M.S. Feld, and R.P. Rava, �??Analytical model for extracting intrinsic fluorescence in turbid media,�?? Appl. Opt. 32, 3585-3595 (1993).
C.M. Gardner, S.L. Jacques, and A.J. Welch, �??Fluorescence spectroscopy of tissue: recovery of intrinsic fluorescence from measured fluorescence,�?? Appl. Opt. 35:1780-1792 (1996).
K.E.Juhani Airaksinen, P.I. Salmela, M.K. Linnaluoto, M.J. Ikaheimo, K. Ahola, and L.J. Ryhanen, �??Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen,�?? Cardiovasc. Res. 27, 942-945 (1993).
R. Reihsner, M. Melling, W. Pfeiler, and E.J. Menzel, �??Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation,�?? Clin. Biomech. 15, 379-386 (2000).
V.M. Monnier, O. Bautista, D. Kenny, D.R. Sell, J. Fogarty, W. Daahms, P.A. Cleary, J. Lachin, S. Genuth, and the DCCT Skin Collagen Ancillary Study Group, �??Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes,�?? Diabetes 48, 870-880 (1999).
P. Hogan, T. Dall, P. Nikolov, American Diabetes Association, �??Economic Costs of Diabetes in the U.S. in 2002,�?? Diabetes Care 26, 917-932 (2003).
M.I. Harris, K.M. Flegal, C.C. Cowie, M.S. Eberhardt, D.E. Goldstein, R.R. Little, H.M. Wiedmeyer and D.D. Byrd-Holt, �??Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults, The Third National Health and Nutrition Examination Survey, 1988-1994,�?? Diabetes Care 21, 518-24 (1998).
M.I. Harris, R. Klein, T.A. Welborn, and M.W. Knuiman, �??Onset of NIDDM Occurs at least 4-7 yr before clinical diagnosis,�?? Diabetes Care 15, 814-819 (1992).
American Diabetes Association Position Statement, �??Screening for Type 2 Diabetes,�?? Diabetes Care 26, S21-S24 (2003).
M.M. Engelgau, K.M.V. Narayan, and W.H. Herman, �??Screening for Type 2 diabetes,�?? Diabetes Care 23, 1563-1580 (2000).
M.H. Dominiczak, J. Bell, N.H. Cox, D.C. McCruden, S.K. Jones, A.Y. Finlay, I.W. Percy-Robb, and B.M. Frier, �??Increased collagen-linked fluorescence in skin of young patients with type 1 diabetes mellitus,�?? Diabetes Care 13, 468-72 (1990).
B.A. Buckingham, J. Uitto, C. Sandborg, T. Keens, T. Roe, G. Costin, F. Kaufman, B. Bernstein, B Landing, and A. Castellano, �??Scleroderma-like changes in insulin-dependent diabetes mellitus: Clinical and biochemical studies,�?? Diabetes Care 7, 163-169 (1984).
M.I. Harris and R.C. Eastman, �??Early detection of undiagnosed diabetes mellitus: a US perspective,�?? Diabetes Metab. Res. Rev. 16, 230-236 (2001).
S.M. Manley, L.C. Meyer, H.A.W. Neil, I.S. Ross, R.C. Turner and R.R. Holman, �??UKPDS 6 Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biologic risk factors,�?? Diabetes Research 13, 1-11 (1990)
J.M. Mooy, P.A. Grootenhuis, H. de Vries, P.J. Kostense, C. Popp-Snijders, L.M. Bouter, R.J. Heine, �??Intraindividual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study,�?? Diabetologia 39, 298-305 (1996).
P. Koefoed Theil, T. Hansen, M. Larsen, O. Pedersen, and H. Lund-Andersen, �??Lens autofluorescence is increased in newly diagnosed patients with NIDDM,�?? Diabetologia 39, 1524-1527 (1996).
T. Abiko, A. Abiko, S. Ishiko, M. Takeda, S. Horiuchi, and A. Yoshida A, �??Relationship between autofluorescence and advanced glycation end products in diabetic lenses,�?? Exp. Eye Res. 68, 361-366 (1999).
S. Wild, G. Roglic, R. Sicree, A. Green, H. King, �??Global burden of diabetes mellitus in the year 2000,�?? in Global Burden of Disease 2000 (World Health Organization, Geneva, 2003).
W. Hanna, D. Friesen, C. Bombardier, D. Gladman, and A. Hanna, �??Pathologic features of diabetic thick skin,�?? J. Am. Acad. Dermatol. 16, 546-553 (1987).
N. Verzijl, J. DeGroot, S.R. Thorpe, R.A. Bank, J.N. Shaw, T.J. Lyons, J.W.J. Bijlsam, F.P.J.G. Lafeber, J.W. Baynes, and J.M. TeKoppele, �??Effect of collagen turnover on the accumulation of advanced glycation end products,�?? J. Biol. Chem. 275, 39027-39031 (2000).
D.L. Price, P.M. Rhett, S.R. Thorpe, and J.W. Baynes, �??Chelating activity of Advanced Glycation Endproduct inhibitors,�?? J. Biol. Chem. 276, 48967-48972 (2001).
S Yeh, O.S. Khalil, C.F. Hanna, and S. Kantor, �??Near-infrared thermo-optical response of the localized reflectance of intact diabetic and nondiabetic human skin,�?? J. Biomed. Optics 8, 534-544 (2003).
N. Yu, B.S. Krantz, J.A. Eppstein, K.D. Ignotz, M.A. Samuels, J.R. Long, and J. Price, �??Development of a noninvasive diabetes screening device using the ratio of fluorescence to Rayleigh scattered light,�?? J. Biomed. Optics. 1, 280-288 (1996).
D.G. Dyer, J.A. Dunn, S.R. Thorpe, K.E. Bailie, T.J. Lyons, D.R. McCance, and J.W. Baynes, �??Accumulation of Maillard reaction products in skin collagen in diabetes and aging,�?? J. Clin. Invest. 91, 2463-2469 (1993).
R. McCance, D.G. Dyer, J.A. Dunn, K.E. Bailie, S.R. Thorpe, J.W. Baynes, and T.J.Lyons, �??Maillard reaction products and theor relation to complications in insulin-dependent diabetes mellitus,�?? J. Clin. Invest. 91, 2470-2478 (1993).
B. Buckingham and K.M. Reiser, �??Relationship between the Content of Lysyl Oxidase-dependent Crosslinks in Skin Collagen, Nonenzymatic Glycosylation, and Long-Term Complications in type 1 Diabetes Mellitus,�?? J. Clin. Invest. 86, 1046-1054 (1990).
L. Brancaleon, G. Lin, and N. Kollias, �??The in vivo fluorescence of tryptophan moieties in human skin increases with UV exposure and is a marker for epidermal proliferation,�?? J. Invest. Dermatol. 113, 977-982 (1999).
R. Gilles, G. Zonios, R.R. Anderson, and N. Kollilas, �??Fluorescence excitation spectroscopy provides information about human skin in vivo,�?? J. Invest. Dermatol. 115, 704-707 (2000).
P. Geladi, J. Nyström, J.W. Eriksson, A. Nilsson, F. Lithner, and B. Lindholm-Sethson, �??A multivariate NIR study of skin alterations in diabetic patients as compared to control subjects,�?? J. Near Infrared Spectroscopy 8, 217-27 (2000).
UK Prospective Diabetes Study (UKPDS) Group, �??Intensive blood-glucose control with sulphonylurias or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),�?? Lancet 352, 837-853 (1998).
J. Nystrom, B. Lindholm-Sethson, L. Stenberg, S. Ollmar, J.W. Eriksson, and P. Geladi, �??Combined nearinfrared spectroscopy and multifrequency bioimpedance investigation of skin alterations in diabetes patients based on multivariate analyses,�?? Med. Biol. Eng. Comput. 4, 9-324 (2003).
The Diabetes Control and Complications Trial Research Group, �??The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,�?? N. Eng. J. Med. 329, 977-986 (1993).
J.C. Finlay, D.L. Conover, E.L. Hull, and T.H. Foster, �??Prophyrin bleaching and PDT-induced spectral changes are irradiance-dependent in ALA-sensitized normal rat skin in vivo,�?? Photochem. Photobiol. 73, 54-63 (2001).
H. Akaike, �??Information theory and an extension of the maximum likelihood principle,�?? Proc 2nd Int�??l Symp Information Theory, 267-281, (1973).
C. Huberty, Applied Discriminant Analysis, (J Wiley and Sons, NY, 1994).
H. Martens and T. Naes, Multivariate Calibration, (John Wiley and Sons, Chichester, 1989).
National diabetes fact sheet: general information and national estimates on diabetes in the United States 2000,�?? (Centers for Disease Control and Prevention, U.S. Department of Health and Human Services Atlanta, GA 2002).
The Third National Health and Nutrition Examination Survey (NHANES III, 1988-94), National Center for Health Statistics, Centers for Disease Control and Prevention (1996), <a href="http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_Reference_Manuals.htm">http://www.cdc.gov/nchs/about/major/nhanes/NHANESIII_Reference_Manuals.htm</a>
Diabetes Detection Initiative, US Department of Health and Human Services,<a href="http://www.ndep.nih.gov/ddi/"> http://www.ndep.nih.gov/ddi/</a>